NeuroScientific Biopharmaceuticals Reports Strong Results from Stem Cell Study on Fistulising Crohn's Disease
Taruga Minerals Hits High-Grade Gold in Rock Chips at East Normanby Project’s Weioko District
McLaren Minerals PFS Confirms Viability of $2.78b McLaren Titanium Project
Market Overview
ASX 200 Index
Separately Managed Advantages
With increased taxes on high superannuation balances, a lot of people are talking about alternative structures for keeping their investments, including a niche product known as a Separately Managed Account.
The Key Number to Watch for Interest Rate Rises
There is endless speculation about which direction official interest rates are heading in Australia and how far and fast they will rise and fall.
Weekly Wrap: Markets edge as Rio-Glencore talks spark change in mining bid
Rio Tinto slides 6% on Glencore all-stock merger talks; BlueScope up 2% after rejecting a $30 offer. ASX 200 drifts -0.1% as deal news dominates.
Gold Set to Shine in 2026 as Banks Forecast Higher Prices and Steady Demand
Gold set for a 2026 rally: JPMorgan sees Gold averaging US$5,055/oz, Goldman expects strong central-bank buying; upside risk keeps investors watching.
Impact Minerals: HPA breakthrough to slash costs and boost margins
AOK: California Moves & Surat Basin Push Ahead of 2026
Cobalt Blue: Kwinana Refinery Progress, Black Mass plan & 2026 Outlook
Axel Ree AXL: Rare Earths & Gallium in Brazil's Lithium Valley — Trial Mining Ahead
Mithril Silver & Gold (MTH.ASX): Copalquin District High-Grade Gold & Silver Upside
Weekly Wrap: Markets edge as Rio-Glencore talks spark change in mining bid
Rio Tinto slides 6% on Glencore all-stock merger talks; BlueScope up 2% after rejecting a $30 offer. ASX 200 drifts -0.1% as deal news dominates.
Rio Tinto and Glencore confirm merger talks to form world's largest mining company
Rio Tinto and Glencore confirm talks on an all-share merger to create the world’s largest mining company, valuing the entity at about US$388B.
BlueScope Steel knocks back “cheap” $13.15B takeover bid
BlueScope rejects a $13.15B SGH/SDI takeover as cheap, saying it undervalues assets, growth and future dividends; unanimous board stands firm.
SGH and SDI Launch $13.15B Takeover for BlueScope via Scheme
SGH and SDI unveil a $13.15B BlueScope bid at $30/sh, 27% premium, seeking 100% via scheme; North American ops to SDI, Australia+RoW to SGH.
Taruga Minerals Hits High-Grade Gold in Rock Chips at East Normanby Project’s Weioko District
Taruga Minerals (ASX: TAR) will look to fast-track exploration of the Weioko gold district in Papua New Guinea after uncovering high-grade gold in rock chips at the East Normanby project.
McLaren Minerals PFS Confirms Viability of $2.78b McLaren Titanium Project
McLaren Minerals (ASX: MML) has released a pre-feasibility study confirming the economic and financial viability of its namesake titanium project in Western Australia.
Brazilian Critical Minerals Generates High-Purity Oxides in Enrichment Testing of Samples from Ema REE Project
Brazilian Critical Minerals (ASX: BCM) has reported that initial bench-scale testing to enrich pregnant liquor solution from its Ema ionic adsorbed clay rare earths project has been completed at a US facility.
Venari Minerals Set to Release Maiden Red Mountain MRE after Further Lithium Mineralisation Success
Venari Minerals (ASX: VMS) has continued its progession toward a maiden mineral resource estimate with further positive drill results from its Red Mountain lithium project in Nevada, USA.
NeuroScientific Biopharmaceuticals Reports Strong Results from Stem Cell Study on Fistulising Crohn's Disease
NeuroScientific Biopharmaceuticals (ASX: NSB) has confirmed that 75% of patients in the first cohort of a study into its StemSmart therapy to treat fistulising Crohn’s disease have demonstrated a positive clinical response following treatment.
Biome Australia Surges with 41% YoY Revenue Growth in Q2 FY26
Biome Australia (ASX: BIO) has reported a robust Q2 FY26, with revenue surging 40.9% year-on-year to $6.48 million, significantly exceeding expectations and reinforcing its trajectory towards its 'Vis
AdAlta inks major CAR-T deal for global development outside China
AdAlta (ASX:1AD) has secured exclusive rights to co-develop Shanghai Cell Therapy Group's BZDS1901 CAR-T therapy outside Greater China, a significant move validating its 'East-to-West' strategy and po
Memphasys Secures CE Mark for Felix System, Unlocking European Market
Memphasys (ASX: MEM) has secured CE Mark approval for its Felix System, unlocking immediate commercial opportunities in Europe and activating binding multi-year contracts in Europe and MENA.
Findi to Fund Expansion Plans with $72m Strategic Investment from Nova Global Opportunties
Findi (ASX: FND) subsidiary Transaction Solutions International (India) will receive a strategic investment of up to $72 million from Nova Global Opportunities Fund to support its rapidly-expanding operations.
Zeotech Advances Methane Control Program into On-Site Landfill Trials in Queensland
Zeotech (ASX: ZEO) will commence a major on-site validation trial of its methane emissions control solution at a North Burnett Regional Council landfill, following execution of a research agreement with Griffith University.
Hydrix secures $2.5m deal to collaborate on development of SynCardia’s total artificial heart technology
Hydrix secures a $2.5m deal with SynCardia to collaborate on Emperor total artificial heart tech, launching a multi-stage development program.
Alcidion Named Preferred EPR Supplier for Over $35M UK Contract
Alcidion named preferred EPR supplier for UK NHS trust; potential >$35m over 7 years as Miya Precision deploys with UHSx starting Q4 FY26.
Galilee Energy Adds to Leaseholding at Zydeco Gas Project in Louisiana
Galilee Energy (ASX: GLL) has secured additional lease agreements associated with the Zydeco project on the US Gulf Coast, expanding the gas and condensate field to now cover a leased area of more than 325 acres.
BPH Energy Raises $1.2m to Support Gas and Neurotechnology Plans
BPH Energy (ASX: BPH) has received strong backing for its petroleum and neurotechnology investments, announcing it had received binding commitments from sophisticated investors to raise approximately $1.2m under a share placement offer.
ETM appoints Ballard Partners and Cohen & Company for Nasdaq listing
Energy Transition Minerals hires Ballard Partners for Nasdaq listing push, with Cohen & Company as US adviser to access capital and critical minerals demand.
BPH Energy planning new capital raising
BPH Energy (ASX: BPH) hits trading halt ahead of a capital-raising announcement; halt to last until Jan 12, 2026 or until market update, size undisclosed.
Silex Systems Secures $28M US DOE Funding for Laser Enrichment Tech, Eyes 10% US Reactor Supply
Silex Systems (ASX: SLX) has secured up to $28 million USD from the US Department of Energy (DOE) for its laser enrichment technology, bolstering its path towards domestic uranium production.
Sprintex Lands Record A$27.4m Mest Water Order, Boosting European Expansion
Sprintex (ASX: SIX) has secured its largest-ever purchase order, valued at A$27.4 million from Mest Water, significantly boosting revenue visibility and marking a major commercial milestone fo
AnteoTech Secures Serum Institute Order, Bolsters Life Sciences Outlook
Serum Institute Fuels Life Sciences Growth
FDA Greenlights Kava as Food, Boosting Calmer Co's US Expansion
The Calmer Co (ASX: CCO) has secured significant regulatory clarity from the US FDA, which confirmed traditionally prepared kava beverages as food products, de-risking its US expansion and dual-catego
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]
Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]
ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]